Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05591118 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Study acronym: PE-TRACT
StatusRecruiting
PhasePhase 3
Started2023-07-17
View on ClinicalTrials.gov ↗

Amendment history

2026-05-15
Study Status v10
Completion pushed: 2027-06-26 → 2027-08-04
2026-04-27
Study Status, Contacts/Locations v9
Re-verified, no change to tracked fields
2025-06-18
Study Status v8
Primary completion date2027-01→2027-03-29
Completion date2028-01→2027-06-26
2025-04-22
2 amendments v6-v7
2 re-verifications since 2025-03-31, no change to tracked fields
2024-05-29
Study Status, Eligibility, Contacts/Locations v5
Study sites11→40
Eligibility criteria+8 characters
[...] steroid pre-medication can be used Life expectancy < 1 year InabilityChronic inability to independently walk prior to the current PE episode (e.g. [...]
Show 4 earlier versions
2024-04-02
Study Status, Contacts/Locations v4
Study sites1→11
2023-07-26
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-08→confirmed 2023-07-17
Study sitesdetails revised at 1 of 1 site
2023-07-14
Study Status v2
Start date2023-05→2023-08
2023-05-08
Study Status, Arms and Interventions v1
Re-verified, no change to tracked fields
2022-10-18
Original filing
PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.
Trial Details
NCT Number NCT05591118
Lead Sponsor NYU Langone Health
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Pulmonary Embolism
Enrollment 500 participants
Start Date 2023-07-17
Primary Completion 2027-03-29 (estimated)
Study Completion 2027-08-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-18